ricrolin
Small moleculeexperimental
Clinical trial activity
3 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
2
Phase 4
0
Earliest trial started May 1, 2011 (NCT02349165)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 3 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ricrolin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03858036 | Phase 3 | Mar 8, 2019 | Center for Sight |
| NCT03080077 | Phase 3 | Jun 30, 2016 | Icahn School of Medicine at Mount Sinai |
| NCT02349165 | N/A | May 1, 2011 | Dr. F.P. Fischer Stichting, Stichting Nederlands Oogheelkundig Onderzoek, UMC Utrecht, Utrecht University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Center for Sight | Academic/Hospital | 1 | 1 | 1 | 2019 |
| Dr. F.P. Fischer Stichting | Academic/Hospital | 1 | 0 | 1 | 2011 |
| Icahn School of Medicine at Mount Sinai | Academic/Hospital | 1 | 1 | 1 | 2016 |
| Stichting Nederlands Oogheelkundig Onderzoek | Academic/Hospital | 1 | 0 | 1 | 2011 |
| UMC Utrecht | Academic/Hospital | 1 | 1 | 1 | 2011 |
| Utrecht University | Academic/Hospital | 1 | 0 | 1 | 2011 |
6 organizations
Page 1 / 1